Hybrid Revascularization
Hybrid Revascularization is a medical procedure with 3 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2/3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
0
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Full Metall Jacket Multilevel Segment
Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease
Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease
Clinical Trials (3)
Full Metall Jacket Multilevel Segment
Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease
Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease
All 3 trials loaded
Drug Details
- Intervention Type
- Procedure
- Total Trials
- 3